Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expected and actual case ascertainment and treatment rates for children infected with hepatitis C in Florida and the United States: epidemiologic evidence from statewide and nationwide surveys.
Delgado-Borrego A, Smith L, Jonas MM, Hall CA, Negre B, Jordan SH, Ogrodowicz M, Raza R, Ludwig DA, Miller T, Lipshultz SE, Gonzalez-Peralta R, Chung RT. Delgado-Borrego A, et al. Among authors: smith l. J Pediatr. 2012 Nov;161(5):915-21. doi: 10.1016/j.jpeds.2012.05.002. Epub 2012 Jul 3. J Pediatr. 2012. PMID: 22765955
The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C.
Schwarz KB, Gonzalez-Peralta RP, Murray KF, Molleston JP, Haber BA, Jonas MM, Rosenthal P, Mohan P, Balistreri WF, Narkewicz MR, Smith L, Lobritto SJ, Rossi S, Valsamakis A, Goodman Z, Robuck PR, Barton BA; Peds-C Clinical Research Network. Schwarz KB, et al. Among authors: smith l. Gastroenterology. 2011 Feb;140(2):450-458.e1. doi: 10.1053/j.gastro.2010.10.047. Epub 2010 Oct 28. Gastroenterology. 2011. PMID: 21036173 Free PMC article. Clinical Trial.
Impact of hepatitis C virus infection on children and their caregivers: quality of life, cognitive, and emotional outcomes.
Rodrigue JR, Balistreri W, Haber B, Jonas MM, Mohan P, Molleston JP, Murray KF, Narkewicz MR, Rosenthal P, Smith LJ, Schwarz KB, Robuck P, Barton B, González-Peralta RP. Rodrigue JR, et al. J Pediatr Gastroenterol Nutr. 2009 Mar;48(3):341-7. doi: 10.1097/MPG.0b013e318185998f. J Pediatr Gastroenterol Nutr. 2009. PMID: 19242286 Free PMC article. Clinical Trial.
Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial.
Goodman ZD, Makhlouf HR, Liu L, Balistreri W, Gonzalez-Peralta RP, Haber B, Jonas MM, Mohan P, Molleston JP, Murray KF, Narkewicz MR, Rosenthal P, Smith LJ, Robuck PR, Schwarz KB. Goodman ZD, et al. Among authors: smith lj. Hepatology. 2008 Mar;47(3):836-43. doi: 10.1002/hep.22094. Hepatology. 2008. PMID: 18167062 Free PMC article.
Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive outcomes in children.
Rodrigue JR, Balistreri W, Haber B, Jonas MM, Mohan P, Molleston JP, Murray KF, Narkewicz MR, Rosenthal P, Smith LJ, Lobritto SJ, Schwarz KB, Robuck PR, Barton B, González-Peralta RP. Rodrigue JR, et al. Hepatology. 2011 May;53(5):1468-75. doi: 10.1002/hep.24248. Hepatology. 2011. PMID: 21351116 Free PMC article. Clinical Trial.
Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach.
Li V, McKay FC, Tscharke DC, Smith C, Khanna R, Lechner-Scott J, Rawlinson WD, Lloyd AR, Taylor BV, Morahan JM, Steinman L, Giovannoni G, Bar-Or A, Levy M, Drosu N, Potter A, Caswell N, Smith L, Brady EC, Frost B, Hodgkinson S, Hardy TA, Broadley SA; Australian Anti-EBV Drugs for MS Working Group. Li V, et al. Among authors: smith l. CNS Drugs. 2025 Jan 10. doi: 10.1007/s40263-024-01153-5. Online ahead of print. CNS Drugs. 2025. PMID: 39792343
Children's executive functioning and health behaviors across pediatric life stages and ecological contexts.
Kelly NR, Kosty D, Bodovski Y, Blackwell CK, Ganiban JM, Neiderhiser JM, Dabelea D, Gilbert-Diamond D, Aschner JL, Bastain TM, Breton CV, Bush NR, Calub CA, Camargo CA, Camerota M, Croen LA, Elliott AJ, Enlow MB, Ferrara A, Hartert T, Joseph RM, Karagas MR, Kelly RS, Lyall K, Magee KE, McEvoy CT, Merced-Nieves FM, O'Connor TG, Santarossa S, Schantz SL, Schmidt RJ, Stanford JB, Straughen JK, Stroustrup A, Talge NM, Wright RJ, Zhao Q, Leve LD; program collaborators for Environmental influences on Child Health Outcomes. Kelly NR, et al. J Behav Med. 2025 Jan 9. doi: 10.1007/s10865-024-00543-w. Online ahead of print. J Behav Med. 2025. PMID: 39786706
13,240 results
You have reached the last available page of results. Please see the User Guide for more information.